X

Ishita Drugs & Industries Ltd Stock Analysis

Small Cap
Evaluated by 119 users | BSE: 524400 | NSE: |
Pharmaceuticals & Drugs
Ishita drugs & industries limited (IDIL), an Ishita Group company  was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.IDIL is engaged in the manufacture of various...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 9.45%4.78%8.45%5.77%4.4%3.06%3.4%4.55%5.12%7.06%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 8510.76.776.55.86.89.114.8
Y-o-Y Gr. Rt.--38%115.1%-37.1%3.4%-6.2%-10.7%15.9%34.3%63.2%
Adjusted EPS (Rs.) 1.360.691.340.960.710.50.610.650.961.56
Y-o-Y Gr. Rt.--49.3%94.2%-28.4%-26%-29.6%22%6.6%47.7%62.5%
Book Value per Share (Rs.) 14.8615.5516.9517.6318.3818.8319.4420.2721.4523.28
Adjusted Net Profit 0.40.20.40.30.20.20.20.20.30.5
Net Op. Cash Flow (Rs. Cr.) -0.10.9-0.20.70.10.30.50.70.81.1
Debt to Cash Flow from Ops -4.860.06-0.840.250.834.330.010.180.260.27
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Ishita Drugs & Industries Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 7.1%16.3%36.4%63.2%
Adjusted EPS 1.5%17.1%36.8%62.5%
Book Value per Share 5.14.86.28.5
Share Price 0.5% 12.6% 7.6% 117.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 9.594.578.255.563.972.693.193.274.586.96
Operating Profit Margin (%) 7.545.415.056.74.454.075.56.685.685.15
Net Profit Margin (%) 5.084.173.744.263.062.293.132.873.143.14
Debt to Equity 0.080.010.040.040.020.200.020.030.04
Working Capital Days 155206981691241411451057249
Cash Conversion Cycle 5084365254645649273
Entity Percentage Holding
Promoters 47.87%
Non-Institutions 52.13%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Ishita Drugs & Industries Ltd's performance infers:

Ishita Drugs & Industries Ltd earnings have grown by 17.1%, whereas share price has appreciated 12.6% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Ishita Drugs & Industries Ltd share prices over the last 10 years. Here is what we found out:

Ishita Drugs & Industries Ltd share price has appreciated -3.2% annually over the past ten years.

Ishita drugs & industries limited (IDIL), an Ishita Group company  was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

IDIL is engaged in the manufacture of various active pharma ingredients (bulk actives and their salts), bulk drug intermediates, excipients and fine chemicals. It has a state-of-art manufacturing facility, in terms of chemical synthesis, quality

Ishita drugs & industries limited (IDIL), an Ishita Group company  was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

IDIL is engaged in the manufacture of various active pharma ingredients (bulk actives and their salts), bulk drug intermediates, excipients and fine chemicals. It has a state-of-art manufacturing facility, in terms of chemical synthesis, quality control and environmental safety.

Ishita Group is a respected member of the Indian business community for more than 3 decades. The group's interests encompass manufacture of a large number of bulk actives and their salts, drug intermediates, fine chemicals, food additives, specialty/ performance chemicals, pharmaceutical formulations, healthcare products, dyes and dye intermediates, distribution of financial products and other businesses. The ishita group derives its key strengths from its strong ethical practices and moral values in business commitments.

The company’s manufacturing facility is located on main State Highway 17, barely 25 km from Ahmedabad city. The plant incorporates facilities that are the state-of-art in chemical synthesis, quality control and energy efficiency. The provision of several different utility systems and equipments covering a large number of unit operations make the plant truly multi-purpose. This imparts the flexibility to alter the product mix in tune with the changing market needs or the needs of the customers for customized products.

The plant is equipped with various kinds of equipment to carry out varied kinds of reactions - ss vessels, glass lined ss reactors (glrs), ss centrifuges, rubber lined centrifuges, condensers, fluid bed dryers, ribbon blender, commuting mill, leaf filters, vibrator separators, multi mill etc. The plant also have various utilities suitable for different processes - oil heating, steam heating, ammonia chilling, brine chilling, compressed air, vacuum systems etc.

Product range of the company includes:

The current product list of Ishita includes APIs and intermediates

APIs

Antibiotics

  • Chloramphenicol bp/usp
  • Chloramphenicol palmitate bp/usp

Fluoro quinolones

  • Norfloxacin ip/usp/bp
  • Enrofloxacin base vet

Sulpha drugs

  • Sulfacetamide plain bp/usp
  • Sulphacetamide sodium (drc)
  • Sulfanilamide

Vitamins

  • Nicotinamide usp (inj.) / cosmetics grade
  • Nicotinic acid bp/usp

Anthelmintics

  • Piperazine hydrate
  • Piperazine citrate / adipate / phosphate

Iodides & citrates (salts)

  • Pot.iodide bp
  • Sod.iodide bp
  • Methyl iodide bp
  • Pot.citrate bp/usp
  • Sod.citrate bp/usp
  • Sod.acid citrate bp
  • Sodium chloride bp (pyrogen free)
  • Potassium chloride bp (pyrogen free)

Excipients

  • Maize starch bp
  • Sod.starch glycolate usp
  • Pumojel (sod.starch glycolate)

Other chemicals

  • Methyl nicotinate
  • Pyrazinamide
  • Salicylanilide
  • Para bromo toluene 99.5%
  • Pyridine hydrobromide
  • Potassium phthalimide
  • Nicotinic acid hydrazide

Intermediaries

  • 4-sulfonamido phenyl hydrazine hcl (celecoxib intermediate)
  • 4-chloro phenyl hydrazine hydrochloride
  • Q-acid and n2 ester (norfloxacin intermediates)
  • Tri methyl sulphonoxium iodide
  • 5 cyano phthalide
  • 7-amino - 3 phenyl coumarin
  • 2-hydroxy methyl 3,5 dimethyl 4-methoxy pyridine (omeprazole int.)
  • Hexa methyl disilazane
  • 5-chloromethopabate
  • Diacetyl sulfanilamide
  • L-alanine benzylester p-toluene sulfonate salt
  • 4 (chloroacetyl) n-methyl sulfonamide
  • Indole - 2 - carboxylic acid
  • Ethyl benzoyl acrylate
  • 4, 4' - dimethyl benzil
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback